Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-026740
Filing Date
2023-06-07
Accepted
2023-06-07 07:15:18
Documents
2
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 6-K form_6-k_pharma_amend_6.htm 6-K 32312
2 EX-4.1 lmdx-ex4_1.htm EX-4.1 432164
  Complete submission text file 0000950170-23-026740.txt   465449
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ 011 44 1786 430411
LumiraDx Ltd (Filer) CIK: 0001685428 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40852 | Film No.: 23997641
SIC: 2834 Pharmaceutical Preparations